.

What is not in the broker's note valuation with a 400p target price is any pricing for the potential in furthering the licensing of their IP in the construction of new, lighter, more natural feeling breast implants.

According to the broker note, "....this project requires little investment by AorTech but, if successful, would result in either a very attractive licence and royalty income or a JV opportunity to disrupt current technologies and supply chains. Not assumed in our projections, but as an indication of the potential value is that a 5% royalty on a 5% global market share would generate an income stream of £2.5m per annum to AorTech."

.

makes the hoped-for progress ........ aye, and there's the rub

“Hoped for” was my phrase to avoid any accusation of ramping. Clearly, if the progress was guaranteed we wouldn’t be here at a market cap of £11m. That said, in my view, the market is pricing AOR from a view of mistrust on its past slip ups. A cynical eye you might say.

chuckle ..... as you already know, i hold a few and may even add

superb chart.

Incredibly strong this morning and high volume.

One to watch next week.

The twenty year chart is amazing!!!

The 10 year chart is pretty good.

Thought I would bump this thread to the top before MAM goes tits up!

Decent update on progress from AOR today. Hopefully will wake this share from its bear market slumbers very soon.

Can’t get this link to work so you know what to do :)

https://www.moneyam.com/action/news/showArticle?id=6288823